Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_assertion type Assertion NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_head.
- NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_provenance.
- NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_assertion evidence source_evidence_literature NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_provenance.
- NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_assertion SIO_000772 20530282 NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_provenance.
- NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_assertion wasDerivedFrom gad-20150221 NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_provenance.
- NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_assertion wasGeneratedBy ECO_0000203 NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_provenance.